RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+12.66%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.53B
AUM Growth
+$3.53B
(+3.1%)
Cap. Flow
-$35.7M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
48.03%
Holding
98
New
16
Increased
28
Reduced
21
Closed
18
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$62.6M |
| 2 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$57.4M |
| 3 |
Amicus Therapeutics
FOLD
|
$39.6M |
| 4 |
Centene
CNC
|
$36.2M |
| 5 |
Krystal Biotech
KRYS
|
$30.4M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$103M |
| 2 |
InflaRx
IFRX
|
$82.5M |
| 3 |
Xencor
XNCR
|
$58.3M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$49.3M |
| 5 |
Penumbra
PEN
|
$47.5M |
Sector Composition
| 1 | Healthcare | 95.47% |
| 2 | Financials | 2.17% |
| 3 | Energy | 0.01% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Centene
CNC
$14.8B
| $36.2M | 1.03% |
+690,870
| New | +$36.2M |
|
|
GRTS
27
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $35.8M | 1.01% |
3,215,994
+862,259
| +37% | +$9.61M |
|
28
UnitedHealth
UNH
$279B
| $34.6M | 0.98% |
141,901
+9,011
| +7% | +$2.2M |
|
29
AnaptysBio
ANAB
$630M
| $34.4M | 0.97% |
609,658
+112,740
| +23% | +$6.36M |
|
30
Xeris Biopharma Holdings
XERS
$1.27B
| $34.3M | 0.97% |
3,000,641
| – | – |
|
|
SYRS
31
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $33.5M | 0.95% |
3,620,376
+1,975,176
| +120% | +$18.3M |
|
|
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
| $33.3M | 0.94% |
813,500
+214,900
| +36% | +$8.8M |
|
33
Replimune Group
REPL
$460M
| $32.2M | 0.91% |
2,197,003
-15,453
| -0.7% | -$227K |
|
34
Teladoc Health
TDOC
$1.37B
| $30.7M | 0.87% |
461,880
+21,980
| +5% | +$1.46M |
|
35
LivaNova
LIVN
$3.09B
| $30.5M | 0.86% |
423,987
-158,700
| -27% | -$11.4M |
|
|
IMGN
36
DELISTED
Immunogen Inc
IMGN
| $30.3M | 0.86% |
13,954,794
+891,027
| +7% | +$1.93M |
|
37
Stoke Therapeutics
STOK
$1.08B
| $29.8M | 0.84% |
+1,021,808
| New | +$29.8M |
|
|
EIDX
38
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $27.3M | 0.77% |
878,403
+26,503
| +3% | +$824K |
|
|
ODT
39
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $27.2M | 0.77% |
740,671
+263,207
| +55% | +$9.66M |
|
40
DexCom
DXCM
$30.9B
| $25.8M | 0.73% |
+172,100
| New | +$25.8M |
|
|
TCRR
41
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $25.7M | 0.73% |
1,799,216
-8,040
| -0.4% | -$115K |
|
|
OXFD
42
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $24.7M | 0.7% |
1,796,477
-204,990
| -10% | -$2.82M |
|
43
Jazz Pharmaceuticals
JAZZ
$7.99B
| $24M | 0.68% |
168,387
-101,093
| -38% | -$14.4M |
|
|
CBIO
44
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $23.9M | 0.68% |
2,008,447
-9,800
| -0.5% | -$117K |
|
|
CBAY
45
DELISTED
Cymabay Therapeutics
CBAY
| $22.5M | 0.64% |
3,138,365
+194,600
| +7% | +$1.39M |
|
46
Akero Therapeutics
AKRO
$3.65B
| $22.4M | 0.63% |
+1,168,802
| New | +$22.4M |
|
|
VAPO
47
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $22.1M | 0.62% |
959,539
-51,777
| -5% | -$1.19M |
|
|
BCEL
48
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $21.5M | 0.61% |
+1,140,306
| New | +$21.5M |
|
49
Adaptive Biotechnologies
ADPT
$1.96B
| $20.5M | 0.58% |
+425,000
| New | +$20.5M |
|
|
MOR
50
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $17.7M | 0.5% |
733,699
-160,101
| -18% | -$3.86M |
|